Biogen Inc

BIIB: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|l!LOCK|m#%y#LOCK|Q^K^Yvg

Biogen Earnings: Growth Portfolio Outpaces Legacy Portfolio Erosion; Guidance Raised

Biogen's second-quarter revenue grew 3% and non-GAAP earnings per share fell 34% year over year. However, management raised full-year guidance for non-GAAP EPS to $15.85-$16.85, or $0.60 higher at the midpoint.

Sponsor Center